Form 8-K - Current report:
SEC Accession No. 0001493152-22-014397
Filing Date
2022-05-19
Accepted
2022-05-19 07:35:40
Documents
14
Period of Report
2022-05-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42195
2 ex99-1.htm EX-99.1 10798
3 ex99-1_001.jpg GRAPHIC 3790
  Complete submission text file 0001493152-22-014397.txt   237239

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abeo-20220517.xsd EX-101.SCH 3063
5 XBRL LABEL FILE abeo-20220517_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE abeo-20220517_pre.xml EX-101.PRE 22615
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3611
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 22941157
SIC: 2834 Pharmaceutical Preparations